Connect with us
European Gaming Congress 2024

Artificial Intelligence

North America digital health market size to bolster at a substantial rate through 2027

Published

on

Pune, India, March 28, 2022 (GLOBE NEWSWIRE) — According to MarketStudyReport, North America digital health market is touted to reach a valuation of USD 261 billion by 2027. The proportion of people suffering from chronic illnesses is rising year by year and has become a cause of concern in North America. Thus, authorities have been taking efforts to introduce several initiatives to build awareness about the benefits of using digital healthcare services.

The research literature, which has been collated and verified by experts, splits the market on the basis of technology, component type, and regional outlook. A study of qualitative and quantitative aspects of each of these segments is also included to provide better clarity to the readers.

The report also houses information on competitive hierarchy and provides a detailed analysis of product profiles of major contenders in this business vertical.

Access sample pages of the report, “North America Digital Health Market Forecasts 2027” in detail along with the table of contents (ToC) @

https://www.marketstudyreport.com/request-a-sample/2506018/

Advertisement
Stake.com

The adoption of IT solutions in healthcare, and the demand for advanced treatments is increasing among patients which is creating a positive industry outlook. Also, high prevalence of chronic diseases like diabetes and heart diseases, increasing incidence of obesity, surging demand for remote patient monitoring services, and growing patient engagement & connectivity are aiding the industry growth.

In addition, increasing awareness about preventive healthcare and availability of funds in various mHealth startups are further boosting market growth. Moreover, a marked surge in the number patients suffering from ailments requiring long-term care (LTC) such as cancer, Alzheimer’s disease, diabetes, and CVDs is also propelling industry growth.

Market segmentation review:

Based on technology gamut, the market is divided into mHealth, [wearable {glucose meters, neurological monitors, pulse oximeters, BP monitors, sleep apnea monitors}, apps {fitness, medical}], telehealthcare [telecare {remote monitoring management, LTC monitoring, activity monitoring, video consultation}] digital health systems [e-prescribing system, EHR] and health analytics. Moving on to component type, digital health industry is arrayed into software, hardware and services.

Asia Pacific Market:

Advertisement
Stake.com

Asia Pacific digital health market is on track to amass a valuation of USD 107.5 billion by the end of 2026, primarily driven by the fast-developing healthcare IT infrastructure in industrialized countries.

Notably, the coronavirus pandemic in 2020 significantly triggered digital transformation in healthcare, with the use of various new-age technologies. A recent study on the uses of telemedicine during the coronavirus pandemic found that 70% participants consider telemedicine is the future of healthcare in India. Such indicators foreshadow a strong growth trajectory for Asia Pacific digital health industry. In 2020, Asia Pacific digital health system segment was worth USD 7 billion. Healthcare informatic technologies connected with medical transcription IT systems are used in super specialty clinics and hospitals. These technologies aid in shortening medical documentation delays and directing more resources into diagnostic procedures. For example, The Indian Health Service in India maintains an EHR for Tribal, IHS, and Urban Indian health care facilities. The Resource and Patient Management System EHR gives many of its establishments’ access to decades of personal health information and epidemiological data on local populations. During COVID-19, telehealth involves bridging the gap between people, clinicians, and health systems, allowing everyone, particularly symptomatic patients, to stay at home and interact with physicians via virtual channels, therefore aiding in the reduction of virus spread. In a recent study on the usage of telemedicine during the coronavirus epidemic, 70% participants agreed that telemedicine represents the future of healthcare in India. Such strong statistics are representing a healthy growth for Asia Pacific digital health industry.

Access sample pages of the report, “Asia Pacific Digital Health Market Forecasts 2027” in detail along with the table of contents (ToC) @

https://www.marketstudyreport.com/request-a-sample/2506020/

Europe Market:

Advertisement
Stake.com

Europe Digital Health market is estimated to surpass a valuation of USD 172.6 billion by 2025 on the back of increasing penetration of gadgets like tablets, smartphones, and other mobile platforms, high demand for remote patient monitoring services, rapidly developing healthcare IT infrastructure, and favorable government policies.

Germany digital health market, which is estimated to be worth USD 47.6 billion by 2027, has constantly stayed at the forefront of digital health transformation by continuously inventing new laws and modifying existing ones to suit present industry needs. Remote-video technology is now being used in medical interactions with healthcare personnel and systems. Especially for elderly persons or kids with ailments which need special medical attention, telemedicine is a blessing in the wake of the pandemic. Telehealth accounted for a whopping 58.4% of Europe digital health market share in 2020, owing to the growing demand for remote monitoring services. When the initial wave of the COVID-19 pandemic hit, Difrent, a digital health business in the UK, came to the rescue with a home PCR test ordering service. They sent 1 million home test kits across the UK and expanded the program from critical healthcare personnel to all UK citizens in two weeks. LifeWatch AG, McKesson Corporation, Philips Healthcare, Cerner Corporation, and Cisco Systems are the leading digital health companies in Europe.

Access sample pages of the report, “Europe Digital health Market Forecasts 2027” in detail along with the table of contents (ToC) @

https://www.marketstudyreport.com/request-a-sample/2506019/

North America Digital Health Market, by Technology Gamut (Revenue, USD Million, 2016-2027)

Advertisement
Stake.com

Telehealthcare

  • Telecare
    • Activity Monitoring
    • Remote Monitoring Management
    • Video Consultation
    • LTC Monitoring

 mHealth

  • Wearable
    • BP Monitors
    • Glucose Meter
    • Pulse Oximeter
    • Sleep Apnea Monitors
    • Neurological Monitors
  • Apps
    • Medical
    • Fitness

Digital Health System

  • EHR
  • E-Prescribing System

Health Analytics

North America Digital Health Market, by Component Type (Revenue, USD Million, 2016-2027)

  • Software
  • Hardware
  • Services

North America Digital Health Market, by Regional Outlook (Revenue, USD Million, 2016-2027)

Asia Pacific

  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Malaysia
  • Indonesia
  • Thailand
  • Singapore
  • Philippines

North America

  • U.S.
  • Canada

Europe

  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Poland
  • Switzerland
  • The Netherlands
  • Sweden
  • Norway
  • Denmark
  • Finland
  • Iceland

North America Digital Health Market, Company Profiles (Revenue, USD Million, 2016-2027)

  • Koninklijke Philips N.V.
  • McKesson Corporation
  • iHealth Lab Inc.
  • eClinicalWorks
  • Cisco Systems Inc.
  • Cerner Corporation
  • Athenahealth Inc.
  • Allscripts Healthcare Solutions Inc.
  • AT&T Inc.
  • AdvancedMD Inc.

Related Report:

Digital Health Market Size, COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

The digital health market is poised to register a period of strong growth by 2027, fueled by the rapidly shifting healthcare industry dynamics. Technological advancements have facilitated a strong and steadily growing bond between the healthcare and technology sectors, enabling humankind to amplify the benefits offered by both industries on a global scale. Meanwhile, MEA digital health market is anticipated to exhibit an impressive CAGR of 17.5% through the analysis timeline. A majority of this growth is expected to come from gulf nations. In fact, it was unveiled last year that the UAE is one of MEA’s biggest adopters of Artificial Intelligence, having invested a total of $2.15 billion in the technology over the past decade. Over the past year, the coronavirus pandemic has emerged as a major proponent for the global digital health market. Consequently, the World Health Organization, recently unveiled the Global Strategy on Digital Health 2020-2025 directive. In the report, the organization underlined the importance of digital health and highlighted how digital health should be an important part of every nation’s health priorities and should help people in such a way that it is safe, ethical, reliable, secure, sustainable, and equitable.

Advertisement
Stake.com

About US:

Market Study Report is a hub for market intelligence products and services.

We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

Our customers partner with Market Study Report, to ease their search and evaluation of market intelligence products and services and in turn focus on their company’s core activities.

If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, is the platform that can help you in achieving any of these objectives.

Advertisement
Stake.com


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Juniper Biologics Expands Distribution Rights for Caris Life Sciences’ Molecular Profiling in the Middle East and Africa

Published

on

juniper-biologics-expands-distribution-rights-for-caris-life-sciences’-molecular-profiling-in-the-middle-east-and-africa

SINGAPORE, June 23, 2024 /PRNewswire/ — Singapore-headquartered Juniper Biologics Pte Ltd (Juniper), a leading healthcare and pharmaceuticals company focused on commercialising novel therapies, has been granted distribution rights for Caris Life Sciences (Caris)’ solid tumour molecular profiling services in the Middle East and Africa (MEA). Caris is the leading next-generation AI TechBio company and precision medicine pioneer. This expansion follows the initial January 2023 distribution rights partnership with Caris for the same services in Southeast Asia (SEA). Juniper is now poised to offer Caris’ advanced solid tumour molecular profiling services across a broader region, enhancing patient access to personalised treatment options.

Caris’ best-in-class molecular profiling, combined with proprietary artificial intelligence, provides more precise and individualized cancer treatments. This profiling approach assesses DNA, RNA, and proteins, revealing a molecular blueprint that identifies treatment options specific to each patient’s cancer. Caris has developed the world’s largest and most informative platform for cancer analysis, featuring the most advanced tumour profiling available, including Whole Exome and Whole Transcriptome Sequencing across over 23,000 genes. By analysing biomarkers found in tumours, Caris helps healthcare providers make informed choices for personalised care.
Juniper Biologics is committed to driving positive change in the pharmaceutical industry on a global scale. Aligned with its mission to deliver transformative therapies through bold scientific innovation, Juniper’s collaboration with Caris will enhance access to quality treatments for patient communities in the Middle East and Africa. Juniper continues to pursue impactful partnerships aimed at uplifting communities and individuals, especially in underserved regions where access to advanced therapies is limited.
Raman Singh, Founder and Chief Executive Officer (CEO) of Juniper Biologics, spoke on the successful acquisition: “Caris molecular profiling bridges the gap between tumour biology and cancer treatments, guiding precision medicine through personalised treatment selection for physicians and their patients. Our exclusive partnership with Caris Life Sciences to distribute this service in the Middle East and Africa will significantly empower healthcare professionals to make informed decisions for their patients. This service enables oncologists to recommend highly personalised treatments that specifically target a patient’s cancer, thereby improving and expanding their care options. This targeted approach offers patients, particularly those with rare or aggressive cancers, an improved quality of life.”
“Caris is pleased to expand the distribution of our molecular profiling services in the Middle East and Africa through our partnership with Juniper Biologics,” said Caris President David Spetzler, MS, PhD, MBA. “This collaboration aligns with Caris’ goal of enabling clinicians worldwide to make the best individualised treatment choices for their patients and ultimately helping to improve patient outcomes.”
This partnership marks a significant milestone in expanding access to personalised medicine and advanced cancer treatment technologies in the Middle East and Africa.
About Juniper Biologics
Backed by The Sylvan Group, Juniper Biologics is a science-led healthcare company focused on delivering novel therapies to improve the health and quality of life of patients, by building a growing presence in Oncology and Oncology Supportive Care, Rare/Orphan Diseases and Gene Therapy. It was founded on a vision to provide treatments for unmet medical needs focused on specialist therapy areas in which it can make the most difference. Through bold and transformative science, Juniper Biologics is committed to creating possibilities that have the potential to become the next generation of life-changing medicines for patient communities in China, Japan, Asia, Australia, New Zealand, Middle East, and Africa.
Website: https://www.juniperbiologics.com/
LinkedIn: https://www.linkedin.com/company/juniper-biologics
About Caris Life SciencesCaris Life Sciences® (Caris) is the leading next-generation AI TechBio company and precision medicine pioneer actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition using molecular science and AI. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced AI and machine learning algorithms, Caris has created the large-scale, multi-modal database and computing capability needed to analyse and unravel the molecular complexity of disease. This convergence of sequencing power, big data, and AI technologies provides an unmatched platform to deliver the next generation of precision medicine tools for early detection, diagnosis, monitoring, therapy selection, and drug development.
Headquartered in Irving, Texas, Caris has offices in Phoenix, New York, Cambridge (MA), Tokyo, Japan and Basel, Switzerland. Caris or its distributor partners provide services in the U.S., Europe, Asia, and other international markets. To learn more, please visit CarisLifeSciences.com.
 

View original content:https://www.prnewswire.co.uk/news-releases/juniper-biologics-expands-distribution-rights-for-caris-life-sciences-molecular-profiling-in-the-middle-east-and-africa-302179643.html

Continue Reading

Artificial Intelligence

2024 Tang Prize Laureates Announced: Six Global Visionaries to Be Honored in Taiwan This September

Published

on

2024-tang-prize-laureates-announced:-six-global-visionaries-to-be-honored-in-taiwan-this-september

TAIPEI, June 22, 2024 /PRNewswire/ — The prestigious 2024 Tang Prize Laureates have been announced, recognizing outstanding contributions in various fields. The Tang Prize in Sustainable Development is awarded to American chemist Omar M. Yaghi. In the field of Biopharmaceutical Science, the prize is jointly awarded to Joel F. Habener, Svetlana Mojsov, and Jens Juul Holst. University Professor Emeritus Hsu Cho-yun of the University of Pittsburgh and Academician of Academia Sinica is honored with the Tang Prize in Sinology. Mary Robinson, a former lawyer and senator, former president of Ireland, former United Nations High Commissioner for Human Rights, and current Chair of The Elders, is awarded the Tang Prize in Rule of Law. These six distinguished laureates will be formally honored at an upcoming ceremony to be held in Taiwan this September.

The Tang Prize in Sustainable Development is awarded to Omar M. Yaghi, for his extraordinary contributions to sustainable development, particularly his pioneering work with Metal-Organic Frameworks (MOFs) and other ultra-porous frameworks that can be tailored for carbon capture, hydrogen and methane storage, and water harvesting from desert air. His research has revolutionized the field of chemistry and materials science, offering transformative solutions for sustainable development through the creation of customizable materials with exceptional properties.
Professor Joel F. Habener, Professor Svetlana Mojsov, and Professor Jens Juul Holst have been jointly awarded the Tang Prize in Biopharmaceutical Science, for the discovery of GLP-1 (7-37) as an insulinotropic factor and the development of GLP-1 (7-37)-based anti-diabetic and anti-obesity drugs.
University Professor Emeritus Hsu Cho-yun is awarded the Tang Prize in Sinology for his exceptional contributions to the field of Sinology. Professor Hsu’s illustrious academic career has been distinguished by his holistic approach to the study of ancient Chinese history, seamlessly integrating an exploration of cultural and intellectual exchanges between China and the world. With his profound erudition and unwavering public spirit, Professor Hsu embodies the quintessential Sinologist, possessing both a deep historical sensibility and a broad, worldly vision.
The Tang Prize in Rule of Law is awarded to Professor Mary Robinson, for her “powerful advocacy for the most disadvantaged in different spheres, including gender equality, poverty alleviation, human rights, and climate justice.” In particular, the Selection Committee noted that her “passionate endeavors demonstrated an effective combination of legal acumen and practical solutions.” The Committee also noted that “from the national to the global stage, legal and political, she has innovatively transformed and expanded the various positions in which she has served to strengthen the rule of law.”
About the Tang Prize
Since the advent of globalization, mankind has been able to enjoy the convenience brought forth by the advancement of human civilization and science. Yet a multitude of challenges, such as climate change, the emergence of new infectious diseases, wealth gap, and moral degradation, have surfaced along the way. Against this backdrop, Dr. Samuel Yin established the Tang Prize in December 2012. It consists of four award categories, namely Sustainable Development, Biopharmaceutical Science, Sinology, and Rule of Law. Every other year, four independent and professional selection committees, comprising many internationally renowned experts, scholars, and Nobel winners, choose as Tang Prize laureates people who have influenced and made substantive contributions to the world, regardless of ethnicity, nationality or gender. A cash prize of NT$50 million (approx. US$1.7 million) is allocated to each category, with NT$10 million (approx. US$ 0.35 million) of it being a research grant intended to encourage professionals in every field to examine mankind’s most urgent needs in the 21st century, and become leading forces in the development of human society through their outstanding research outcomes and active civic engagement.
Photo – https://mma.prnewswire.com/media/2444565/2024.jpg

View original content:https://www.prnewswire.co.uk/news-releases/2024-tang-prize-laureates-announced-six-global-visionaries-to-be-honored-in-taiwan-this-september-302179271.html

Continue Reading

Artificial Intelligence

Key Tech Stocks Optimizing AI Usability and Infrastructure for a $20-Trillion Future

Published

on

key-tech-stocks-optimizing-ai-usability-and-infrastructure-for-a-$20-trillion-future

USA News Group CommentaryIssued on behalf of Avant Technologies Inc.
VANCOUVER, BC, June 21, 2024 /PRNewswire/ — USA News Group – Several big winners have been made already in the ongoing artificial intelligence (AI) revolution. However, there’s clearly none bigger than chipmaking giant NVIDIA Corporation (NASDAQ: NVDA), which just surpassed two of its big tech peers to become the most valued publicly-traded company on the planet. To put it into perspective, NVIDIA’s market cap is currently larger than each of Europe’s largest stock markets, while lucky investors who bet $1000 on NVIDIA stock just ten years ago would be sitting on an extra $297,600 today. Now as analysts are predicting that AI and cryptocurrency could inject $20 trillion into the global economy by 2030, the best minds in the tech sector are moving their pieces into place to secure their piece of the pie. Behind the scenes, tech stocks are optimizing the infrastructure, security, and usability of AI, including new developments from Avant Technologies Inc. (OTCQB: AVAI), International Business Machines Corporation (IBC) (NYSE: IBM), Cloudflare, Inc. (NYSE: NET), and Accenture plc (NYSE: ACN).

Known as a pioneer in the sector for its innovative AI technology, Avant Technologies Inc. (OTCQB: AVAI) has improved its main product, Avant AI™. This sophisticated AI system, celebrated for its advanced machine and deep learning capabilities, is adaptable across a wide range of industries.
In a recent strategic development, Avant has signed a Binding Letter of Intent (BLOI) with Flow Wave, LLC (FW), a Florida-based leader in immersible computer server technology. This agreement allows Avant to acquire up to 50 cutting-edge immersible computer servers from FW in a deal valued at $50 million.
“Avant’s revolutionary AI software platform is poised to transform the landscape of data center management,” said William Hisey, CEO of Avant.  “By integrating proprietary machine learning algorithms with open-source innovations into these servers, Avant is developing a highly intelligent system designed to optimize resource allocation, enhance performance, and drive unprecedented levels of efficiency and automation. This marks the beginning of a new era for Avant Technologies, positioning us at the forefront of the supercomputer-driven data center industry and setting new standards for managing and storing AI applications.”
Flow Wave Immersible AI Supercomputer Servers are great for heavy AI and machine learning tasks because they have strong processing power, meaning they can analyze data faster and more efficiently. Their special cooling technology uses less energy, saving money and reducing environmental impact. The servers are also compact and easy to set up, making them ideal for data centers with limited space. Plus, their design helps them last longer and require less maintenance.
Avant plans to tackle the challenges of the digital age by buying up to 50 of these high-performance servers from Flow Wave. These servers, with their advanced cooling technology, boost performance and save energy. This deal shows Avant’s dedication to providing top-notch AI infrastructure and improving efficiency. More details about the transaction will be shared once a definitive agreement is finalized.
One of the most active tech giants in the AI space is International Business Machines Corporation (IBC) (NYSE: IBM), which recently released a new methodology through its IBM Research® wing called LAB (Large-Scale Alignment for ChatBots), through an open-source project called InstructLab with its subsidiary Red Hat®, which IBM acquired for $34 billion in 2019. The InstructLab project builds on the LAB technique for a community-driven approach to language model development through skills and knowledge training.
As well, IBM has teamed up with WPP and LinkedIn to launch a new business-to-business (B2B) solution powered by IBM’s AI and data platform watsonx, designed to reinvent how B2B markets identify and engage clients and prospects across the buying journey. WPP Open for B2B will help marketers solve complex B2B marketing challenges, accurately identify and engage buying groups, and improve clients’ return on investment.
“B2B marketers have been focused on creating truly personalized, relevant and consistent experiences for buying groups at scale for years,” said Jonathan Adashek, Senior Vice President of Marketing and Communications at IBM. “Our collaboration with WPP and LinkedIn provides real-time, actionable insights that are based on trusted data. We are excited to create and use these new, powerful and trusted AI solutions to deliver a force multiplier for B2B marketing.”
Cloud-based security solution provider Cloudflare, Inc. (NYSE: NET) recently announced the general availability of its AI Gateway platform, dubbed as a unified interface for managing and scaling the generative AI workloads of clients. Since its beta launch in September 2023, AI Gateway has handled over 500 million requests and is now ready for full client use.
The general availability release followed upon another Cloudflare announcement of a collaboration with Hugging Face, the leading open and collaborative platform for AI builders, for a one-click-simple global deployment for AI applications. With its Workers AI platform now generally available, Cloudflare became the first serverless inference partner integrated on the Hugging Face Hub for deploying models, enabling developers to quickly, easily, and affordably deploy AI globally, without managing infrastructure or paying for unused compute capacity.
“Workers AI is one of the most affordable and accessible solutions to run inference,” said Matthew Prince, CEO and co-founder, Cloudflare. “With Hugging Face and Cloudflare both deeply aligned in our efforts to democratize AI in a simple, affordable way, we’re giving developers the freedom and agility to choose a model and scale their AI apps from zero to global in an instant.”
Reporting impressive generative AI revenues in its latest Q3 2024 fiscal results has caused shares of Accenture plc (NYSE: ACN) to jump this week, reporting more than $900 million in generative AI bookings in the latest quarter alone.
“Our actions to stay laser-focused on the needs of our clients are clear in our third quarter results,” said Julie Sweet, Chair and CEO of Accenture. “We… achieved two significant milestones this quarter — with $2 billion in Generative AI sales year-to-date and $500 million in revenue year-to-date — which demonstrate our early lead in this critical technology.”
Prior to the financial report, Accenture announced its intent to acquire Italian-based network services company, Fibermind, which specializes in fiber and mobile 5G networks deployment, as well as infrastructure engineering services. Together, Accenture and Fibermind will offer clients network engineering capabilities, deep industry knowledge, and technology assets powered by automation, robotics, data and AI.
Prior to its surge into the position as the world’s most valuable publicly-traded company, NVIDIA Corporation (NASDAQ: NVDA) made a pair of announcements, further cementing its role in the AI revolution.
The first was the announcement of its NVIDIA Omniverse Cloud Sensor RTX, a set of microservices that enable physically accurate sensor simulation to accelerate the development of fully autonomous machines of every kind, allowing developers to test sensor perception and associated AI software at scale in physically accurate, realistic virtual environments prior to real-world deployment.
The second announcement was the NVIDIA AI Computing by HPE, a portfolio of AI solutions and joint go-to-market integrations that enable enterprises to accelerate adoption of generative AI, co-developed with Hewlett Packard (HP).
“Generative AI and accelerated computing are fueling a fundamental transformation as every industry races to join the industrial revolution,” said Jensen Huang, Founder and CEO of NVIDIA. “Never before have NVIDIA and HPE integrated our technologies so deeply – combining the entire NVIDIA AI computing stack along with HPE’s private cloud technology – to equip enterprise clients and AI professionals with the most advanced computing infrastructure and services to expand the frontier of AI.”
All NVIDIA AI Computing offerings by HPE will be available through a combined marketing strategy involving sales teams, channel partners, and training. This strategy includes a global network of system integrators such as Deloitte, HCLTech, Infosys, TCS, and Wipro. These integrators will assist enterprises across various industries in running complex AI workloads.
Source: https://usanewsgroup.com/2023/10/26/unlocking-the-trillion-dollar-ai-market-what-investors-need-to-know/ 
CONTACT:
USA NEWS [email protected](604) 265-2873
DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. USA News Group is a wholly-owned subsidiary of Market IQ Media Group, Inc. (“MIQ”). MIQ has been paid a fee for Avant Technologies Inc. advertising and digital media from the company directly. There may be 3rd parties who may have shares Avant Technologies Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ own shares of Avant Technologies Inc. which were purchased as a part of a private placement. MIQ reserves the right to buy and sell, and will buy and sell shares of Avant Technologies Inc. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by MIQ has been approved by the above mentioned company; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through further private placements and/or investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

View original content:https://www.prnewswire.co.uk/news-releases/key-tech-stocks-optimizing-ai-usability-and-infrastructure-for-a-20-trillion-future-302179234.html

Continue Reading

Trending